Guggenheim initiated coverage of Personalis (PSNL) with a Buy rating and $6 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSNL:
- Personalis Q1 2025 Earnings: Growth and Strategic Advances
- Personalis Inc.: Strong Financial Performance and Promising Future Prospects Drive Buy Rating
- Personalis Inc. Receives Buy Rating from Michael Matson Due to Strong Financial Performance and Positive Outlook
- Personalis price target raised to $9 from $8 at H.C. Wainwright
- Personalis Reports Strong Q1 Growth in Genomics